FLOW CYTOMETRY
BioMedha provides flow cytometry analysis to help clients identify and characterise cell populations of interest and to measure the therapeutic effect on a cell subset’s frequency and function. Flow cytometry is often used in drug discovery for target validation, compound screening, and biomarker analysis.
The team at BioMedha offers standard developed and validated assays as well as bespoke and customised assay support to help clients identify a specific immune cell subset or function relevant to the client’s project.
Our flow cytometry expertise includes:
- Access to fresh whole blood
- Cell profiling and subsetting
- Compound screening for their therapeutic effect on cell subsets frequency and function
- Whole blood assays
- Immune cell assays (stimulation and inhibition)
- Anti-inflammatory and pro-inflammatory endpoint assays
- Phenotyping analysis
- Receptor occupancy
- Cell detection and quantification
- Extracellular vesicle detection
- Functional assays
- Cytotoxicity and cell proliferation
- Phosphorylation of proteins
- Intracellular antigens or cytokines or chemokines
- Biomarker analysis
- Multiplexing: 4 lasers and 13 filters
- Cell types: whole blood, immune cells, primary cells, immortal cell lines, recombinant cell lines, and iPSC derived cells.